BIODELIVERY SCIENCES INTL (BDSI) Stock Analyst Ratings
USA - NASDAQ:BDSI - Common Stock
5.59
0 (-0.09%)
5.6
+0.01 (+0.18%)
ChartMill assigns a Buy % Consensus number of 74% to BDSI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.48. This target is -1.88% below the current price.
BDSI was analyzed by 13 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about BDSI.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
BDSI was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-15 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-01-21 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-11-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-08-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-11 | HC Wainwright & Co. | Maintains | Buy |
BIODELIVERY SCIENCES INTL / BDSI FAQ
What is the average price target for BIODELIVERY SCIENCES INTL (BDSI) stock?
13 analysts have analysed BDSI and the average price target is 5.48 null. This implies a price decrease of -1.88% is expected in the next year compared to the current price of 5.59.
What is the consensus rating for BDSI stock?
The consensus rating for BIODELIVERY SCIENCES INTL (BDSI) is 73.8462 / 100 . This indicates that analysts generally have a positive outlook on the stock.